A detailed history of Ameritas Advisory Services, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 7,538 shares of AZN stock, worth $496,603. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,538
Previous 13,572 44.46%
Holding current value
$496,603
Previous $1.06 Million 44.52%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$76.67 - $87.62 $462,626 - $528,699
-6,034 Reduced 44.46%
7,538 $587,000
Q2 2024

Jul 29, 2024

BUY
$66.81 - $80.83 $111,706 - $135,147
1,672 Added 14.05%
13,572 $1.06 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $505,023 - $575,691
8,275 Added 228.28%
11,900 $806,000
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $422,461 - $472,905
-6,826 Reduced 65.31%
3,625 $244,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $240,593 - $266,007
3,710 Added 55.04%
10,451 $707,000
Q2 2023

Jul 25, 2023

SELL
$69.91 - $75.81 $286,491 - $310,669
-4,098 Reduced 37.81%
6,741 $482,000
Q1 2023

Apr 28, 2023

BUY
$63.15 - $71.6 $7,893 - $8,950
125 Added 1.17%
10,839 $752,000
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $6,288 - $8,171
-116 Reduced 1.07%
10,714 $726,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $2,226 - $5,701
42 Added 0.39%
10,830 $594,000
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $61,808 - $74,199
-1,043 Reduced 8.82%
10,788 $713,000
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $34,379 - $41,413
617 Added 5.5%
11,831 $785,000
Q4 2021

Feb 07, 2022

BUY
$54.02 - $63.83 $605,780 - $715,789
11,214 New
11,214 $653,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $204B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.